Bristol-Myers Squibb’s Recent >$20bn M&A Spree Should Reward Patient Investors (NYSE:BMY)


Keyboard with a green button - Order now

Zerbor/iStock via Getty Images

Investment Overview

Bristol-Myers Squibb Company (NYSE:BMY), the Princeton, New Jersey-based Big Pharma concern, experienced a poor year in terms of share price performance in 2023.

BMY is currently the seventh largest of the “Big 8” U.S.-headquartered global

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *